MiMedx Group Inc (MDXG) Stock Forecast & Price Target
MiMedx Group Inc · NASDAQ
$4.69+0.12 (+2.63%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering MiMedx Group Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $6.00 to $10.00, a moderate spread. The average target of $8.40 sits 79% above the current $4.69. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to MiMedx Group Inc.
As of Sep, 5 of 5 firms rate MDXG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MDXG EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.00 – $0.07 · 3 analysts · -71% YoY
Next period, 3 analysts expect MiMedx Group Inc to earn $0.04 a share (range $0.00 – $0.07), versus $0.14 a year earlier. Full-year consensus is $-0.05, growing to $0.20 the year after.
REVENUE · NEXT QUARTER
$76.5M
Range $71.6M – $80.3M · 3 analysts · -35% YoY
Revenue is expected to reach $76.5M (range $71.6M – $80.3M), -35.3% year-over-year. Full-year consensus is $269.8M, rising to $328.6M next year.
Top analysts covering MiMedx Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDXG.
#1
Chase Knickerbocker
Craig-Hallum · Rank #19
Buy
$8.00+70.6% to target
Overall win rate
61%
+ Follow
#2
Anthony Petrone
Mizuho · Rank #86
Buy
$10.00+113.2% to target
Overall win rate
46%
+ Follow
#3
Ross Osborn
Cantor Fitzgerald · Rank #166
Buy
$12.00+155.9% to target
Overall win rate
33%
+ Follow
#4
David Turkaly
JMP Securities · Rank #346
Buy
$6.00+27.9% to target
Overall win rate
33%
+ Follow
#5
Sarah James
Cantor Fitzgerald
Buy
$8.00+70.6% to target
Coverage
—
+ Follow
MDXG stock forecast FAQ
What is MDXG's average 12-month price target?+
The 5 analysts with a live target average $8.40 for MiMedx Group Inc over the next 12 months, ranging from a $10.00 high to a $6.00 low.
Is MDXG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MDXG?+
The Street-high target is $10.00 (Lake Street), and the Street-low is $6.00 (Citizens). The average of all 5 active targets is $8.40.
How many Wall Street analysts cover MDXG?+
5 analysts have an active rating on MiMedx Group Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering MDXG?+
Among analysts who currently cover MDXG, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #19). Their current call is Buy with a $8.00 target.
What is MiMedx Group Inc's projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.00 – $0.07) across 3 analysts. Full-year EPS is projected at $-0.05, rising to $0.20 the following year.
How much revenue is MiMedx Group Inc expected to report next quarter?+
Consensus revenue is $76.5M (range $71.6M – $80.3M). Full-year revenue is projected at $269.8M, growing to $328.6M next year.
Have analysts been upgrading or downgrading MDXG lately?+
As of Sep, 5 of 5 firms rate MDXG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDXG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
